<h1>Pharma Giant Rolls Out Strategic Capital Raise, Targets Global Expansion with Oversubscribed Rights Issue</h1> A pharmaceutical company launched a rights issue to raise capital for global expansion and operational enhancement. The issue, priced at 1 per share, has already attracted 26.03% subscription within two days. The company aims to strengthen its international market presence, invest in research and development, and improve working capital. The rights issue reflects the organization's strategic approach to long-term growth and financial sustainability in the pharmaceutical sector.